Clik here to view.
武田薬品、CD30陽性皮膚T細胞リンパ腫の治療薬としてのアドセトリス（ブレンツキシマブ・ベドチン）に対する肯定的見解をCHMPより取得
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社(TSE:...
View ArticleClik here to view.
Samsung Bioepis Receives Regulatory Approval for Europe’s First Trastuzumab...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) marketing authorization of ONTRUZANT®, a biosimilar referencing Herceptin® (trastuzumab), for the treatment of...
View ArticleClik here to view.
PeptiDream Announces Discovery Collaboration Agreement with Bayer
KAWASAKI, Japan PeptiDream Inc., a public Kanagawa-based biopharmaceutical company (“PeptiDream”)(TOKYO:4587) announced today that it has entered into a multi-target discovery collaboration with...
View ArticleClik here to view.
Research Institute Focusing on Study of Motion Analysis in Sports to Be...
BOULDER, Colo. & TOKYO A think tank research body called the Institute of Motion Analysis (IMA) comprising some of the world’s leading sports scientists, exercise physiologists, coaches,...
View ArticleClik here to view.
Xona Microfluidics, LLC Issued European Patents for Neuron Research Device
DURHAM, N.C. Xona Microfluidics, LLC, a biotechnology company focused on manufacturing and distributing microfluidic devices to neuroscientists and laboratories worldwide, today announced that the...
View ArticleClik here to view.
Preceptis Medical Announces Series B Financing and Global Growth Strategy for...
MINNEAPOLIS Preceptis Medical, Inc., manufacturer of the Hummingbird TTS (Tympanostomy Tube System) technology that enables a conscious sedation alternative to general anesthesia for placing ear...
View ArticleClik here to view.
Octapharma捐赠3050万国际单位该公司药品 Nuwiq以治疗发展中国家的血友病患者
瑞士拉亨 (美国商业资讯) — 2017: Octapharma欣然宣布，与美国马萨诸塞州North Andover的Project SHARE合作完成一次慈善捐赠，捐赠3050万国际单位的该公司人体细胞系衍生重组第VIII因子制品Nuwiq®。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
オクタファルマ、開発途上国の血友病患者を治療するために当社のNuwiq製剤3050万国際単位を寄付
スイス・ラーヘン （ビジネスワイヤ） — 2017年:オクタファルマは、米国マサチューセッツ州ノースアンドーバーのプロジェクト・シェアと連携して、ヒト細胞株由来の組み換え型第VIII因子製剤Nuwiq®3050万国際単位の慈善寄付を完了したことを発表します。 本プレスリリースではマルチメディアを使用しています。リリースの全文はこちらをご覧ください。：...
View ArticleClik here to view.
Preceptis Medical宣布面向中国的B轮融资和全球增长战略
明尼阿波利斯 (美国商业资讯) — Preceptis Medical, Inc.是Hummingbird...
View ArticleClik here to view.
Puma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive...
LOS ANGELES Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, and Specialised Therapeutics Asia, an international biopharmaceutical company with strategic focus and expertise in...
View ArticleClik here to view.
SCIEX and NUS Faculty of Science Announce Plans to Launch New Training Centre...
SINGAPORE SCIEX, a global leader in life science analytical technologies, and the Protein and Proteomics Centre (PPC) under the Department of Biological Sciences at the National University of...
View ArticleClik here to view.
米国FDAがSimcyp Simulator (PBPK) の活用範囲を拡大
ニュージャージー州プリンストン （ビジネスワイヤ） — モデルを活かした医薬品開発およびレギュラトリーサイエンスにおけるグローバルリーダーであるサターラ社は本日、米国食品医薬品局 (FDA) が同社のPBPK Simcyp® Population-based Simulator、Simcyp Pediatric SimulatorおよびCardiac Safety...
View ArticleClik here to view.
FDA Renews and Expands its Portfolio of Simcyp Simulator (PBPK) Licenses
PRINCETON, N.J. Certara®, the global leader in model-informed drug development and regulatory science, today announced that the US Food and Drug Administration (FDA) has greatly expanded its use of...
View ArticleClik here to view.
OSAKA GAS: Pilot Project Launched in Thailand to Explore Biogas Refining and...
NAKHON SI THAMMARAT, Thailand & OSAKA, Japan In collaboration with Thai company Agriculture of Basin Company Limited (“ABC”), OSAKA GAS CO.,LTD. (“OSAKA GAS”) (TOKYO: 9532) launched a pilot...
View ArticleClik here to view.
Kyowa Hakko Kirin Announces FDA Acceptance for Filing and Priority Review...
TOKYO Kyowa Hakko Kirin Co., Ltd. (TOKYO:4151) (President and CEO: Nobuo Hanai, “Kyowa Hakko Kirin”) today announces that the U.S. Food and Drug Administration (FDA) has accepted for review the...
View ArticleClik here to view.
Takeda Initiates Phase 1 Clinical Trial of Zika Vaccine Candidate
OSAKA, Japan Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that its purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate (TAK-426) has...
View ArticleClik here to view.
エマウスライフサイエンス社、第59回アメリカ血液学会年次総会にて、Endari™（L-グルタミン経口粉末薬）に関する第3相臨床試験結果を発表
カリフォルニア州トｰランス市 （ビジネスワイヤ） — エマウス社は、2017年12月9日~12日にジョージア州アトランタで開催される第59回米国血液学会（ASH）年次総会で、鎌状赤血球症治療薬Endari（L-グルタミン経口粉末薬）の第3相臨床試験結果を発表する予定です。 尚、...
View ArticleClik here to view.
Fluence Signs Agreement for Six C-MABR Plants in Guizhou Province China with...
MELBOURNE, Australia & NEW YORK Fluence Corporation Limited (ASX:FLC) (“Fluence” or the “Company”), a global leader in decentralized water and wastewater treatment solutions, has signed a...
View ArticleClik here to view.
Enanta Announces That AbbVie’s MAVIRET™ (glecaprevir/pibrentasvir) Is Now...
WATERTOWN, Mass., Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a chemistry-driven biotechnology company dedicated to creating and developing small molecule drugs for viral infections and liver...
View ArticleClik here to view.
Takeda Appoints Toshio Fujimoto, MD, MBA, as General Manager of the Health...
OSAKA, Japan Takeda Pharmaceutical Company Limited [TSE: 4502] announced today that Toshio Fujimoto, MD, MBA has been appointed General Manager of the Health Innovation Park in Shonan. The...
View Article